API reference

Cinnarizine

CAS number
298-57-7
Molecular formula
C26H28N2
Molecular weight
368.5 g/mol
Cinnarizine — 2D structure
2D structure (PubChem)

About this molecule

First synthesized by Janssen Pharmaceuticals in 1955, cinnarizine is an anti-histaminic drug mainly used for the control of vestibular disorders and motion sickness. Cinnarizine is a specific calcium channel blocker that primarily works on the central vestibular system to interfere with the signal transmission between vestibular apparatus of the inner ear and the vomiting centre of the hypothalamus. Cinnarizine could be also viewed as a nootropic drug because of its vasorelaxating abilities (due to calcium channel blockage), which happen mostly in brain. Combination use of cinnarizine with other nootropics, such as [piracetam] resulted in enhanced effect of boosting brain oxygen supply.

Source: DrugBank, via PubChem.

Identifiers

IUPAC name
1-benzhydryl-4-[(E)-3-phenylprop-2-enyl]piperazine
InChIKey
DERZBLKQOCDDDZ-JLHYYAGUSA-N
SMILES
C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4
Other CAS numbers recorded
16699-20-0
PubChem CID
1547484

Also known as

cinnarizine · Stugeron · Dimitron · Folcodal · Labyrin · Midronal · Mitronal · Stutgeron

Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.

Tell us the grade, the quantity and the market.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com